Armistice Capital »

Caleres shares owned by Armistice Capital

Quarter-by-quarter ownership of Caleres (CAL) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Caleres

Tip: Access up to 7 years of quarterly data

All positions including Caleres held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Caleres by Armistice Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $125k 12k 10.54

More positions owned by Armistice Capital

State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Agios Pharmaceuticals (AGIO)
Cytokinetics Com New (CYTK)
Ptc Therapeutics I (PTCT)
Travere Therapeutics (TVTX)
Madrigal Pharmaceuticals (MDGL)
Immunovant (IMVT)
Supernus Pharmaceuticals (SUPN)
Neurocrine Biosciences (NBIX)
Freshpet (FRPT)
Incyte Corporation (INCY)
Dyne Therapeutics (DYN)
Amazon (AMZN)
Ironwood Pharmaceuticals Com Cl A (IRWD)

View all positions for Armistice Capital

Top funds holding Caleres

FMR
BlackRock
Vanguard Group
Vanguard Capital Management
Dimensional Fund Advisors
American Century Companies
Arrowstreet Capital, Limited Partnership
Neuberger Berman Group
Invenomic Capital Management
Charles Schwab Investment Management
State Street Corporation
Paradigm Capital Management
Goldman Sachs Group
Geode Capital Management
D. E. Shaw & Co

View all funds holding Caleres